2015
DOI: 10.1016/j.jiac.2015.08.017
|View full text |Cite
|
Sign up to set email alerts
|

Synergy of ambroxol with vancomycin in elimination of catheter-related Staphylococcus epidermidis biofilm in vitro and in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
19
0
3

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(24 citation statements)
references
References 32 publications
2
19
0
3
Order By: Relevance
“…During local immune activation it can dampen inflammation signals [27] and prevent pathogenic super infection by species such as Staphylococcus aureus [1; 2]. It can also act as a facultative pathogen forming biofilms on surgically implanted materials [5; 21; 49]. Recently a more distinct method of immune interaction via specific sub-dermal dendritic cells has been described [26] involving activation of the IL1 and IL17 signaling pathways.…”
Section: Introductionmentioning
confidence: 99%
“…During local immune activation it can dampen inflammation signals [27] and prevent pathogenic super infection by species such as Staphylococcus aureus [1; 2]. It can also act as a facultative pathogen forming biofilms on surgically implanted materials [5; 21; 49]. Recently a more distinct method of immune interaction via specific sub-dermal dendritic cells has been described [26] involving activation of the IL1 and IL17 signaling pathways.…”
Section: Introductionmentioning
confidence: 99%
“…[27][28] More importantly, in vitro studies have demonstrated ABX's activity against bacterial infections. [21,29] These novel pharmacologic properties of ABX will greatly expand its application scope and amount, and its biological activity modulation studies are of high significance, which can be employed to deal with emerging problems related to its massive clinical administration. Therefore, in this work, the hostguest complexation between CB [7] and ABX was first studied, followed by the demonstration of CB [7]'s capability in modulating the antibacterial activity of ABX, in order to provide a simple, yet efficient method to regulate the biological activity of ABX, in this case, when used as an antimicrobial agent.…”
Section: Introductionmentioning
confidence: 99%
“…Premature infants are at a high risk of CoNS infections (6). drug for treatment of the MDR S. epidermidis (11). However, resistance to vancomycin has been frequently reported among the staphylococci (12,13).…”
Section: Introductionmentioning
confidence: 99%